OR WAIT null SECS
March 08, 2021
Manufacturing of the vaccine will take place at Baxter’s fill/finish sterile manufacturing facilities located in Bloomington, IN.
March 03, 2021
With funding from the federal government, Merck will expand capacity to produce J&J’s COVID-19 vaccine.
In a pandemic, genetic vaccines offer several advantages over traditional approaches.
AstraZeneca has announced that the mass rollout of its COVID-19 vaccine has begun via the COVAX initiative.
March 02, 2021
The rapid and efficient delivery of innovative treatments through the COVID-19 pandemic has demonstrated the value of collaborations within the bio/pharma industry.
March 01, 2021
Distribution of the first one-dose vaccine for COVID-19 to start in early March.
February 25, 2021
The company will join the network of approved manufacturers of the lipid excipients.
February 23, 2021
New data shows that the COVID-19 vaccines can be stored at standard freezer temperatures for up to two weeks.
February 22, 2021
Once the vaccine has been authorized, Sanofi will provide Johnson & Johnson with access to its vaccine manufacturing plant in Marcy l’Etoile, France, to formulate and fill vials of the vaccine, at a rate of 12 million doses per month.
February 17, 2021
The companies have expanded their existing partnership to include 40 Million Doses of COVID-19 vaccine for South Korea.